Creating Robust Compliant Quality Systems and Programs

Description

This comprehensive whitepaper guides organizations in building robust Quality Management Systems (QMS) aligned with FDA and international standards. It introduces FDA’s Quality Management Maturity (QMM) program launched in 2024-2025, which shifts from deficiency identification to encouraging manufacturers to pursue higher maturity levels. The document covers 16 critical QMS elements: establishing QMS with ICH Q10 principles, regulatory compliance including QMSR and ISO 13485:2016, SOPs, document control with ALCOA++ principles, risk management per ICH Q9(R1), training and competency, CAPA systems with AI enhancement, supplier quality management, internal audits, equipment calibration with predictive maintenance, change control, product traceability, complaint handling and recalls, non-conformance management, and validation systems. Emphasizes integration of AI/ML, cybersecurity controls for connected devices, and adoption of emerging technologies while maintaining quality culture and continuous improvement.